Related Experiment Video
Updated: Nov 30, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Targeting immunogenic cell death in cancer
Asma Ahmed1,2, Stephen W G Tait1,2
1Cancer Research UK Beatson Institute, Glasgow, UK.
Immunogenic cell death (ICD) activates the immune system against cancer by releasing damage-associated molecular patterns (DAMPs) from dying tumor cells. This process enhances anticancer drug efficacy and can induce vaccine-like effects.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Immunogenic cell death (ICD) is a crucial mechanism where cancer cell death stimulates an immune response.
- Certain therapies, including chemotherapy and radiotherapy, can induce ICD, activating the host's immune system against tumors.
Purpose of the Study:
- To review the various cell death modalities associated with ICD.
- To identify the damage-associated molecular patterns (DAMPs) released during ICD.
- To explore the mechanisms by which DAMPs activate the immune system and discuss the therapeutic potential of ICD in cancer immunotherapy.
Main Methods:
- Literature review of studies on immunogenic cell death.
- Analysis of damage-associated molecular patterns (DAMPs) involved in ICD.
- Examination of immune activation mechanisms triggered by ICD.
Main Results:
- ICD involves the release of DAMPs such as calreticulin, heat-shock proteins, ATP, HMGB1, type I IFNs, and IL-1 family cytokines.
- These DAMPs promote the activation of tumor-specific immune responses.
- ICD can enhance the efficacy of anticancer therapies and elicit anticancer vaccine effects.
Conclusions:
- ICD represents a promising strategy for cancer immunotherapy by bridging direct tumor cell killing with the induction of antitumor immunity.
- Harnessing ICD offers significant therapeutic potential but also presents challenges that require further investigation.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...